Invited Speakers from Overseas

Pr Roland Baron, DMD PhD is Professor of Medicine at Harvard Medical School (Boston, USA) and Professor and Head of the Division of Bone and Mineral Research at Harvard School of Dental Medicine, since January 2008.
Between 1977 and 2007 Dr Baron was Professor of Medicine, Orthopaedics and Cell Biology at Yale University School of Medicine (New Haven, USA).
Dr Baron spent a sabbatical in the Dept of Orthopedics at Tokyo University Graduate School of Medicine (Prof. Tanaka) in 2021-22 as a Fellow of the JSPS.
He is the founder (1977) and past Editor-in-Chief (1985-2013) of Bone.
Between 1994 and 2002, he also held the position of Vice-President and Head of Bone Diseases at Hoechst Marion Roussel and then at Aventis.
In 2002 he founded ProSkelia/ProStrakan, a company devoted to the discovery and development of new drugs for bone diseases.
Since 2006, Dr Baron has been on several scientific and global advisory boards of pharmaceutical (Amgen, Merck, Lilly, UCB, Radius) and small biotech companies.
Dr Baron has been the President of the European Calcified Tissue Society 2008-2011 (ECTS) and of the American Society for Bone and Mineral Research 2014-15 (ASBMR), and is presently co-Chair of the International Federation of Musculoskeletal Research Societies (IFMRS, 2016-present).
Dr Baron has published more than 400 scientific papers in the field of bone biology and bone diseases, including in Science, Nature, Cell, New England Journal of Medicine, Nature Medicine, Cell Metabolism, Developmental Cell, Aging Cell, JCI, PNAS (USA), J Cell Biology, JBMR, Bone etc.
For this work, Dr Baron received the MERIT and the Kreshover awards from the NIH, the Louis Avioli and the William F. Neuman awards from ASBMR, the Harold Copp award from IBMS, the Excellence in Research award from ECTS, and the Gluck award from the Rheumatology Research Foundation.

Dr. Brian Chalmers is an orthopedic surgeon specializing in hip and knee musculoskeletal care, including primary hip and knee replacement, partial knee replacement, complex and revision hip and knee replacement, and periprosthetic fractures and infections. Dr. Chalmers is trained in manual, computer-navigated, and robotic surgical techniques to achieve individualized patient treatment goals. He uses the latest surgical methods, medical research, and perioperative rapid-recovery and pain management protocols to provide the best possible care and outcomes for his patients.

Dr. Chalmers earned his undergraduate degree at the University of Notre Dame, where he graduated summa cum laude with a degree in Science-Business and a minor in Greek and Roman studies. He also received the Senior Award from the College of Science for balanced outstanding academic achievement, leadership, service, and integrity. He graduated summa cum laude from the University of Kansas School of Medicine, where he was elected as President of the Alpha Omega Alpha Honor Society.

Dr. Chalmers completed his orthopedic surgical residency at the Mayo Clinic in Rochester, Minnesota and was appointed an Administrative Chief Resident in his final year. Desiring to specialize in advanced reconstructive surgical care of hip and knee conditions, he completed an additional year of training as a clinical fellow at the Adult Reconstruction and Joint Replacement at HSS where he was granted the Clinical Excellence Award.

Dr. Chalmers is dedicated to advancing the field of hip and knee replacement by improving surgical techniques and optimizing perioperative patient care. He has published over 80 peer-reviewed publications and book chapters. He has presented his research in dozens of international, national, and regional meetings. He was selected for and completed the John Insall Knee Society Travelling Fellowship in 2022. He also serves on the Editorial Board and manuscript reviewer for several orthopedic journals.

Dr Tae Joon Cho is a professor at Seoul National University College of Medicine Seoul Republic of Korea and has served as a pediatric orthopaedic surgeon at Seoul National University Childrens Hospital since nineteen ninetysix He graduated from the same medical school and completed his orthopaedic residency at Seoul National University Hospital His early research focused on fracture healing and distraction osteogenesis and his current work centers on molecular genetics and genomics in skeletal disorders Clinically he specializes in pediatric hip diseases limb reconstruction and orthopaedic management of genetic skeletal disorders including osteogenesis imperfecta and various skeletal dysplasias

He has held multiple leadership positions including Director of Seoul National University Childrens Hospital Chairman of the Department of Orthopaedics at Seoul National University College of Medicine President of the AsianPacific Paediatric Orthopaedic Society and President of the Korean Paediatric Orthopaedic Society Korean ASAMI and the Korean Orthopaedic Research Society He is an active member of numerous international academic organizations including the International Pediatric Orthopaedic Think Tank the Skeletal Dysplasia Management Consortium and the International Clinical Council for FOP He also serves as an editor or reviewer for several leading journals in orthopaedics and genetics

He has authored twentythree book chapters and twohundredfortysix scientific articles Beyond medicine he actively pursues his passion for music as a clarinetist performing with the Korean Doctors Orchestra the Asian Doctors Orchestra and the World Doctors Orchestra

Dr. Michael Collins is an internationally recognized physician scientist with over 25 years of experience in bone biology. He has deep experience in caring for, studying, and conducting clinical trials in patients with disorders of bone and mineral homeostasis with a special focus on rare disorders of mineral homeostasis. He was the leader of the Skeletal Disorders Section at the National Institutes of Health for over 25 years. In this role, he was the Principal Investigator and conducted 10 mostly early phase clinical trials, including first-in-human and first-in-disease, as well as drug repurposing trials, 9 physiology studies, and 7 preclinical trials.
His preclinical translational work involved the development of in vitro and in vivo models of the disorders under investigation, as well as the development and study of novel therapeutics tested in these models. He has developed and refined diagnostic tools for the quantification of disease burden and treatment efficacy. This work has played an important role in the approval of new or repurposed drugs to treat patients.
He is a strong advocate for patients and was a founding member and leader of the Fibrous Dysplasia Foundation (now Fibrous Dysplasia/McCune-Albright Alliance), and the International Consortium of Fibrous Dysplasia/McCune-Albright syndrome. He currently the Chair of the Advisory Committee of the Rare Bone Disease Alliance, and has served as an advisor to many rare disease patient support groups.
He has been deeply involved in training and mentoring his entire career, serving in leadership positions at the NIH including the Interinstitute Endocrine Training Program, the Medical Research Scholars Program, the Clinical Research Training Program, and the Physician Scientist Training Program. He has been a long-term educator in and currently serves on the Board of Directors of the NIH Foundation for Advanced Education in the Sciences. He has mentored over 40 physicians and scientists over his career.

Dr. Felicia Cosman is a clinical scientist, endocrinologist/osteoporosis specialist and Professor of Medicine at Columbia Univ. She has been Co-Editor in Chief of the journal Osteoporosis International since 2016. She received the ACE Distinction in Endocrinology Award in 2019 and the ASBMR Bartter Award for clinical research in September 2020.
Dr. Cosman has been involved in many studies evaluating osteoporosis therapeutics with a main focus on anabolic medications and treatment sequencing. She investigated the effects of teriparatide on cellular action in the iliac crest and in the human femoral neck in patients undergoing hip arthroplasty. She performed a series of studies that investigated cyclic, combination and sequential regimens of teriparatide with antiresorptives (including bisphosphonates, denosumab, raloxifene and estrogen). Dr. Cosman has also been a primary investigator evaluating the efficacy and safety of abaloparatide and romosozumab for osteoporosis. She is well known for work on optimizing anabolic treatment regimens, longterm treatment strategies in postmenopausal women, and implementing therapeutic goals for osteoporosis management. She led the ASBMR/BHOF task force on goal directed therapy culminating in the position statement published in JBMR in 2024.

Dr. DiGiovanni is an internationally recognized foot and ankle surgeon who has taught surgery and lectured about his subspecialty around the world. He is currently Professor of Orthopaedic Surgery at Harvard Medical School, Chief Emeritus of the Foot and Ankle Service, and Vice Chair of Academic Affairs in the Department of Orthopaedic Surgery at Massachusetts General Hospital in Boston. He is Past President of both the American Orthopaedic Foot and Ankle Society as well as the North American Orthopedic Foot Club. Dr. DiGiovanni has cofounded the Joe DiMaggio Sports Foot and Ankle Center as well as the MGH Foot and Ankle Research and Innovation Lab, FARIL, in Boston. He has been honored numerous times by his peers as one of America's Top Surgeons and has been perennially recognized as one of Boston's Top Doctors. Dr. DiGiovanni has served on the surgical advisory board of numerous global companies, published over three hundred peer review articles, edited five medical textbooks, and helped gain patents and FDA approval for many foot and ankle technologies designed to improve patient care. He has been a consulting physician for athletes from many different sports programs, including the US Ski Team, several US Olympic teams, the NFL, NBA, WNBA, MLB, PGA, Boston Ballet, Boston Cannons Men's Lacrosse, Boston Breakers Women's Soccer, Boston College, Northeastern University, Boston University, Harvard College Athletics, Formula One Racing, and the Premier League. For the past twenty eight years, however, Dr. DiGiovanni's greatest professional commitment has always been to the patients he cares for and the residents and fellows he teaches each day.

Dr. Margaret Fok is a Consultant and the Deputy of Chief of Service of the Department of Orthopaedic and Traumatology, Queen Mary Hospital. She is also an Honorary Clinical Associate Professor of The University of Hong Kong.

Dr. Margaret Fok had her undergraduate medical training in University of Otago, New Zealand and underwent her orthopaedic training in Queen Mary Hospital, Hong Kong. She has special interests in hand and wrist surgeries, soft tissue injuries of the elbow and microsurgeries and has worked under:

Professor Diego Fernandez, Bern, Switzerland for the management of complex wrist problems
Professor Fu-Chen Wei for soft tissue coverage in limbs
Professor David Chuong for nerve reconstruction in brachial plexus injuries
Professor Yuen- Kuen Tu for the management of complex hand conditions and brachial plexus injuries
Professor Roger Van Riet for management of elbow pathologies

She is also leading the musculoskeletal infection multidisciplinary team within the Department of Orthopaedic and Traumatology, Queen Mary Hospital.

Dr Margaret Fok currently holds positions in many international as well as regional and local orthopaedic societies:

International Society of Orthopaedic Surgery and Traumatology (SICOT)
Executive Committee
Education Academy Chair

International Societies of Arthroscopy, Knees Surgery and Orthopaedic Sports Medicine (ISAKOS)
Godmother
Deputy Chair, Education Committee

Asia Pacific Orthopaedic Association (APOA)
President, Hand and Upper Limb Society

The Hong Kong Society for Surgery of the Hand (HKSSH)
Honorary Treasurer

She has published book chapters and articles on hand, wrist and compressive neuropathies in esteemed orthopaedic journals. She is a reviewer in many indexed journals and is the Section Editor of Hand and wrist in Journal of Bone and Joint Surgery (American).

Dr. Thorsten Gehrke,

Thorsten Gehrke holds the position of Medical Director and Chief Physician at the ENDO-Klinik Hamburg, Germany, which is doing about 8.000 Joint Replacements / Year.

The ENDO Klinik was founded at a spezialized center for Joint Replacements in 1976. It is the biggest institution for TJA in Europe and one of the biggest in the world.
Today the amount of surgeries is about 8.000 Joint Replacement surgeries, , 650 Spine Surgeries and 2.500 Sport Orthopedic Surgeries
He graduated as Orthopedic Surgeon in 1997 from the University of Kiel / Germany. During his training he worked for two years from 1993 to 1995 at the ENDO Klinik in Hamburg.
From 1999 until today he is constantly working at the ENDO-Klink, where he became the leading position as Medical Director in 2005.
Thorsten Gehrke is a highly-experienced orthopaedic surgeon, providing the broad spectrum of treatment for painful joints. One of his main focus is primary and revision hip and knee replacement and septic revision surgery in hip and knee.
Thorsten Gehrke is member and Honorary Member of several national and international Societies. He is also author of several books and chapters about septic and aseptic revision surgery. Thorsten Gehrke has published more than 300 Peer Reviewed Manuscripts and wrote more than 30 Book Chapters
Dr. Gehrke performed difficult surgeries in all corners of the planet from China, India to South Africa and Latin America, totally in 40 different countries.
Additionally, he got worldwide reputation by organizing and chairing together with Dr. Javad Parvizi the International Consensus Conference on Periprosthetic Joint Infections (PJI) in Philadelphia in 2013 and the International Consensus Meeting (ICM) in 2018.
Together with Dr. Javad Parvizi he was the chairman of the International Consensus Meeting (ICM) about PJI in 2025 in Istanbul / Türkiye
Thorsten Gehrke is a visiting Professor in numerous Universities, like Buenos Aires, Santiago de Chile and Shanghai.

Dr. Gibson is A proud Virginia native, Dr. Gibson graduated Cum Laude with a Bachelor of Science degree from the University of Richmond. His passion for sports and sports medicine began in Richmond, as he competed on a national and international level in the 110 and 400 meter hurdles and various sprint relays for the University. After graduation he was awarded an Armed Forces scholarship to attend the Medical College of Virginia School of Medicine. Upon receiving his MD, he was commissioned in the US Navy and completed an Internship in General Surgery. Serving on the USS Nassau (LHA-4) for Caribbean, Mediterranean and Middle East deployments, Dr. Gibson received personal awards including the Navy Commendation Medal, National Defense Service Medal and various unit commendations. Upon his return he completed his orthopaedic surgery residency at Naval Medical Center Portsmouth, Virginia, serving as chief resident during his final year. He pursued additional fellowship training in Orthopaedic Trauma at Tampa General Hospital and Pelvis and Acetabulum (Hip) Reconstruction at Los Angeles County and Good Samaritan Hospitals. He subsequently led the orthopaedic trauma service at Naval Medical Center Portsmouth. After his honorable discharge, Dr. Gibson began his civilian practice at Eastern Virginia Medical School and Atlantic Orthopaedic Specialists where he began his practice of orthopaedic hip, knee and shoulder reconstruction and replacement and orthopaedic sports medicine. He is a Team Physician for Old Dominion University.
Dr. Gibson is active in leadership of the Virginia Orthopaedic Society and the American Academy of Orthopaedic Surgeons (AAOS). In 2015, Dr. Gibson received the Virginia Orthopaedic Society Career Award. He has published in peer reviewed journals and has special interest in minimally invasive joint replacement and preservation, including the popular direct anterior hip replacement or “jiffy hip.” Dr. Gibson is board certified by the American Board of Orthopaedic Surgery in Orthopaedic Surgery and Orthopaedic Sports Medicine. Second only to the satisfaction of service and treatment of his patients, Dr. Gibson’s greatest professional achievement has been his election to Secretary on the Board of Councilors of AAOS and progression to Chair elect and Chair of this organization that is the deliberative body of the AAOS representing orthopaedic surgeons in all states, regional societies, Puerto Rico, US Territories, Canada and the US Military. Personally, Dr. Gibson lists his lifetime achievement as being able to convince his lovely wife to marry him more than 30 years ago.

Dr. Erik N. Hansen is a Professor of Clinical Orthopaedic Surgery and Section Chief in the Arthroplasty Division at UCSF. Dr. Hansen holds the William R. Murray Endowed Chair in Orthopaedic Surgery.
His clinical and academic interests revolve around primary total joint arthroplasty, including the direct anterior approach to hip replacement surgery, as well as complex revision surgery and complications following total joint replacement.
Apart from his clinical practice, Dr. Hansen has a strong commitment to clinical research dating back to his medical school education. At that time, he took an additional year off to work in an orthopaedic basic science laboratory to understand the fundamentals of fracture healing. In residency, he was selected from his class to do an extra year of research, during which time he worked on several clinical projects focused on total joint replacement, orthopaedic trauma, and medical education. Over the past several years, multiple projects which he has collaborated on have been recognized for prestigious national awards, including the James A. Rand Young Investigator Award, the Mark Coventry Award, and the Chitranjan Ranawat Award. He currently serves as the UCSF lead investigator collaborating with several other major academic institutions on multicenter, prospective randomized clinical trials focused on improving outcomes following revision joint replacement surgery.

Prof. In-Ho Jeon, MD, PhD
First Vice President of SICOT | Professor of Orthopaedic Surgery, Asan Medical Center, Seoul, Korea

Prof. In-Ho Jeon is a globally recognized shoulder and elbow surgeon and current First Vice President of SICOT (Société Internationale de Chirurgie Orthopédique et de Traumatologie). He is Professor of Orthopaedic Surgery at the University of Ulsan, Asan Medical Center, the largest referral hospital in Korea.
After graduating from Kyungpook National University and completing his residency, he pursued advanced training as a Chevening Scholar at the University of Nottingham, UK under Prof. Angus Wallace, and later as a research fellow at the Mayo Clinic, USA with Prof. Bernard Morrey.
Prof. Jeon has authored over 200 peer-reviewed articles and several book chapters on elbow arthroscopy, heterotopic ossification, elbow instability, osteoarthritis, and superior capsular reconstruction for irreparable rotator cuff tears. His research has advanced joint-preserving surgery and improved global understanding of elbow biomechanics and shoulder reconstruction.
He has served as President of the APOA Hand & Upper Limb Society, Chair of the SICOT Shoulder & Elbow Committee, and Congress Chair of the APOA Hand & Upper Limb Meeting (2023). He is also Associate Editor of the Journal of Shoulder and Elbow Surgery and Section Editor of the Journal of Orthopaedic Surgery.
Widely respected as a surgeon, researcher, and mentor, Prof. Jeon has received multiple awards from the European Shoulder and Elbow Society and the Korean Orthopaedic Association. His leadership reflects a commitment to global inclusivity, education, and innovation, strengthening collaboration across regions and generations of surgeons.

Ho Joong Kim is Professor with tenure in the Department of Orthopedic Surgery at Seoul National University College of Medicine and Seoul National University Bundang Hospital where he also serves as Head of the Spine Center and the Smart Simulation Center. He specializes in spinal deformity and degenerative lumbar spine surgery.

Dr Kim earned his medical degree master of science and doctor of philosophy at Yonsei University and completed residency and fellowship training in orthopedic surgery at Yonsei Severance Hospital. He gained international experience as a research scholar at Columbia University Spine Hospital in New York.

He is an active member of major professional societies including the Korean Orthopedic Association the Korean Society of Spine Surgery the North American Spine Society AO Spine and the International Society for the Study of the Lumbar Spine. He also serves on editorial boards and as a reviewer for leading spine journals.

Dr Kim has received numerous academic honors including international presentation and research awards as well as national academic prizes. He has authored several textbooks and more than one hundred sixty peer reviewed international journal articles contributing significantly to advancements in adult spinal deformity surgery biomechanics and minimally invasive techniques.

Through his clinical practice leadership and research Dr Kim continues to advance the field of spine surgery in Korea and worldwide.

Dr. Han Jo Kim is an Attending Spine Surgeon and Professor of Orthopedic Surgery specializing in Cervical Spine and Scoliosis Surgery. After his residency at HSS, he completed a spine fellowship in adult and pediatric spinal deformity and scoliosis surgery followed by a sub-specialized fellowship in cervical spine surgery at Barnes-Jewish Hospital at Washington University in St. Louis. Currently serving as the Director of the Complex Spine and Scoliosis center at HSS, Spine Fellowship Director and Chair of the Fellowship Committee at HSS. He currently holds the David B. Levine Endowed Chair in Scoliosis at HSS.

Dr. Kim has dedicated his time as a volunteer surgeon at the FOCOS hospital in Ghana, West Africa where he has treated some of the most rare and complex spinal deformities in pediatric and adult patients, performing hundreds of successful operations. He currently serves on the Board of Directors for the FOCOS Hospital.

Dr. Kim has authored more than 400 peer-reviewed scientific articles and more than 65 book chapters and He is actively involved in the education of residents, fellows, and physician assistants. He has trained over 50 fellows and residents in his tenure as the Fellowship Director at HSS and has mentored over 35 international research fellows from 12 different countries. Through the AO Spine Foundation, he has been invited by international leaders in spine surgery to author surgical reference guides that teach other spine surgeons performing scoliosis surgery. He was also selected by the Scoliosis Research Society for the prestigious Edgar G. Dawson Fellowship in 2013 and subsequently was selected for the Scoliosis Research Society Traveling Fellowship in 2017 and has also served as the IMAST Chair in 2020. He is also an active member of the Cervical Spine Research Society and also serves on the Board of Directors for the Scoliosis Research Society.

Dr. Emily Kraus is a Clinical Assistant Professor at Stanford Childrens Orthopedic and Sports Medicine Center trained in the specialty of Physical Medicine and Rehabilitation sports medicine. She has research and clinical interests in endurance sports medicine, injury prevention, running biomechanics, prevention of bone stress injuries, and the promotion of health and wellness at any age of life. Dr. Kraus is the director of the FASTR Program, which stands for Female Athlete Science and Translational Research. The FASTR program is supported by the Wu Tsai Human Performance Alliance and seeks to close the gender gap in sports science research with an emphasis on early identification and interventions to prevent injury and identify ways to optimize performance in female athletes. Dr. Kraus is also a member of the U.S. Olympic and Paralympic Committee Womens Health Task Force and is the medical director of the Stanford Childrens Motion Analysis and Sport Performance Lab. She has completed nine marathons including the Boston Marathon twice and one ultramarathon. With running and staying physically active as one of her personal passions, she recognizes the importance of fitness for overall wellbeing and the prevention of chronic medical conditions.

Dr. Leo Kroonen is a hand and upper extremity surgeon whose career has bridged both military service and civilian medicine. He leads the Department of Orthopedic Surgery and Podiatry at the Southern California Permanente Medical Group in San Diego, one of the largest orthopedic programs in California, where he is focused on finding new ways to improve musculoskeletal care delivery. He is also part of the UCLA Hand Transplant Team.

Before joining Kaiser Permanente, Dr. Kroonen spent twenty one years in the US Navy, deploying to combat zones in Afghanistan and Iraq. Along the way, he earned recognition for leadership and innovation, including the Kaiser Innovation Award and honors from national and international orthopedic societies. He was also an AOA JOA Traveling Fellow. He has published widely, served on editorial boards, and spoken at conferences around the world, always with the goal of advancing the field of orthopedic surgery.

Dr. Kroonen completed a bachelor's degree at Stanford University, medical degree at Drexel University, and Master of Health Care Delivery Science at Dartmouth College. He completed residency training in Orthopedic Surgery at Naval Medical Center San Diego and fellowship in Hand and Microvascular Surgery at Thomas Jefferson University and the Philadelphia Hand to Shoulder Center. Outside of work, he's most at home in the ocean, either surfing or shaping his own surfboards. He's also a proud father of two. Professionally, his passion lies in reimagining how healthcare is delivered to meet the needs of an aging and growing population.

Dr Dave Lee is the Head, Division of Sports Surgery, Department of Orthopedics, National University Hospital Singapore . His main interests are complex knee ligament reconstruction; meniscus and cartilage preservation surgery.

He has authored more than 90 peer reviewed articles and 10 book chapters on sports surgery. He has delivered over 100 podium lectures as faculty in overseas conferences.

Dr Lee holds appointments on the boards of ASEAN Society for Sports Medicine and Arthroscopy (ASSA) and Asia Pacific Knee Arthroscopy and Sports Medicine Society (APKASS). He is the past president of ASSA in 2023.

He has served on the Knee Preservation committee of the International Society of Arthroscopy, Knee surgery and Orthopedic Sports Medicine (ISAKOS) since 2021. Dr Lee is appointed to the Editorial boards of the American Journal of Sports Medicine, Arthroscopy Journal, Video Journal of Sports Medicine and the Singapore Medical Journal.

It is my tremendous honor to interact with colleagues at the Japanese Orthopaedic Association. I am an orthopedic oncologist and clinical translational researcher in bone biology. I am currently a Professor with Tenure, Wayne O. Southwick Endowed Professor (2016-Present), at the Yale University School of Medicine in USA. My clinical interest is in skeletal metastases. I completed Orthopaedic Oncology Fellowship at MGH/Boston Children's Hospital in 1997. I was Tenured Professor at Columbia University, New York, until 2016. I am president-Elect (2024-2025) and President (2025-2026) of the Musculoskeletal Tumor Society (MSTS) and Board Member of the International Society of Limb Salvage (ISOLS). I am pondering upon "How can we do something different, new, and better for patients with skeletal metastases and pathological fractures?" I am also Principal Investigator of National Institute of Health (NIH) Research Grants and served numerous NIH/DOD/OREF Review Panels in USA. I look forward to more collaborations with Japanese colleagues for better care of patients and advancement of science.

I am an orthopaedic spine surgeon and the Spine Program Lead at the Toronto Western Hospital of the University Health Network, at the University of Toronto, Department of Surgery with a clinical practice focused on spinal deformities. I am the current President of the Ontario Spine Society, past Chair of the AO Spine Knowledge Forum Deformity, and past Chair of the Scoliosis Research Society (SRS) Adult Deformity Committee and Awards committee and past member of the Worldwide Course committee. I am a member of the University of Toronto Spine Program Council and education and research committee. I serve and have served as abstract reviewer for international meetings including SRS, IMAST, SICOT and North American Spine Society. I have led several multi-center international prospective studies through AO Spine, including the prospective Evaluation of Elderly Deformity Surgery study (PEEDS), and the study of interpretation and management of intra-operative multi-modality neuromonitoring (SDIM) in complex spinal deformity surgery. I have a longstanding and active leading role, locally, nationally and internationally, in education and teaching, particularly in spine deformity surgery. I have trained over 200 surgeons in-training and hosted a number of international surgeons in-practice. I am active in designing several complex spine surgery instrumentations, including osteotomy set. I am on the editorial board and reviewing committee for the Global Spine Journal, Spinal Deformity Journal and the Spine Journal. I have received numerous international awards for outstanding research papers including Whitecloud Award, Russell S. Hibbs Clinical Award, NASS Award, and CSS Deborah Scarlett Award. I have received several awards for excellence in teaching including Best Teacher Award from U of T Spine Program, and Individual Teaching Excellence Award from the Department of Surgery, and the Centre of Excellence Award from the AO Spine

Jagdeep Nanchahal is Professor of Hand, Plastic and Reconstructive Surgery at the University of Oxford. He set up one of the first orthoplastic surgery centres in the UK. He is a passionate advocate for evidence-based medicine. He was a member of NICE guideline development groups on complex, including open (2016, 2022), and non-complex (2016) fractures. He was co-editor of the Standards for the Management of Open Fractures published by the British Orthopaedic and Plastic Surgery Associations (2009, 2019) and contributed to the majority of the chapters. He continues to teach trainees on the management of these injuries and has lectured widely on the subject in the UK and abroad.

James A Nunley, M.D. is the J. Leonard Goldner Endowed Professor and Chairman Emeritus of the Department of Orthopedic Surgery at Duke University Medical Center. Dr. Nunley has served as President of the American Society of Reconstructive Microsurgery, the American Orthopedic Foot and Ankle Society, the Eastern Orthopedic Association, the Southern Orthopedic Association, the Orthopedic Learning Center in Rosemont, Illinois, the North Carolina Orthopedic Association, the North Carolina Society for Surgery of the Hand, the Hand Forum, and the Southeastern Hand Club. He was awarded honorary membership in the Israeli Foot and Ankle Society, the Swiss Foot and Ankle Society and the Hellenic Orthopedic Society Dr. Nunley has given more than 400 national and international presentations, and has authored more than 300 publications in peer-reviewed journals. Dr Nunley has authored two textbooks and sits on the editorial board of several Orthopedic journals. Dr. Nunley has been the recipient of the prestigious American/British/Canadian Traveling Fellowship presented by the American Orthopedic Association, and the Goldner Award for the most outstanding research paper and the Mann Award for the best clinical paper by the American Orthopedic Foot and Ankle Society. Additionally, he has received the Bassett Award as the outstanding teacher by the Duke orthopedic residents. Graduating from Duke University with a BS degree in Chemistry, he then attended Tulane University Medical Center in New Orleans, Louisiana, completing his MS/MD degree. Dr. Nunley continued on to the University of California, Los Angeles to train for two years in general surgery, before completing his four-year orthopedic residency training at Duke Medical Center in Durham, North Carolina. Dr Nunley then joined the Duke faculty in 1980.

Shawn O'Driscoll is Professor of Orthopedic Surgery at the Mayo Clinic College of Medicine and Science in Rochester MN He graduated from medical school at the University of Toronto CA then went on to do his PhD training orthopedic residency and fellowships in both upper extremity surgery and arthroscopy He then did a fellowship in shoulder and elbow surgery and biomechanics research at the Mayo Clinic then practiced shoulder elbow and trauma surgery at the University of Toronto where he founded the Cartilage Research Lab He was recruited to move the Cartilage Research Lab to Mayo Clinic and served as President of the International Cartilage Repair Society He was the Founder and Course Director of the Mayo Clinic Teach the Teachers Advanced Surgical Skills Elbow Course for twenty five years and is the Founding President of the Global Elbow Network
Recently retired from clinical practice he continues to lead the Elbow Research Team at Mayo Clinic and to innovate His inventions and contributions to the field of elbow surgery have been adopted worldwide These include the Congruent Elbow Plating System the Anatomic Radial Head prosthesis and the Latitude linkable Total Elbow Prosthesis Dr ODriscoll has developed a step wise safety driven technique that has proven highly effective in reducing the incidence of iatrogenic nerve injury during elbow arthroscopy He has also been a pioneer in elucidating the mechanisms of elbow instability and classifying fracture dislocations He lectures extensively six continents and is recognized as a leading authority in elbow surgery and research
Shawn is an outdoor enthusiast and cyclist. He has kayaked the Grand Canyon, canoed and camped in most of the MN Boundary Waters Canoe Area and has twice completed segments of the Tour de France. He has served as a leader in Community Bible Study. He is devoted to helping the needy in underdeveloped countries of the world. by mentoring others to Teach The Teachers.

Dr. Javad Parvizi, MD, FRCS, has recently assumed the role of Professor of Orthopedic Surgery at Acibadem University in Istanbul, boasting an impressive career spanning over 25 years in surgery and research. His extensive experience includes conducting more than 10,000 surgical procedures, with a notable expertise in performing over 1,000 hip joint preservation surgeries.From 2003-2023, he served as the Director and Vice Chair of Research at the Rothman Institute. During his illustrious career, he has authored over 1,000 peer-reviewed scientific articles (with an H-index of 137 and a world ranking of 1302), penned 18 textbooks, and garnered over 100 awards from prestigious medical organizations worldwide. Dr. Parvizi has a stellar track record of securing research funding from prominent institutions, including the National Institutes of Health, Department of Defense, Orthopedic Research and Education Foundation, Musculoskeletal Transplant Foundation, and the Arthritis Foundation.
After completing medical school in the UK, Dr. Parvizi embarked on a four-year surgical training in cardiothoracic surgery. He then ventured to the US in 1995, where he pursued a Research Fellowship in Molecular Biology, followed by an orthopedic surgery residency, both at Mayo Clinic. Subsequently, he undertook a fellowship in Switzerland, focusing on the management of hip disorders in young adults, during which he trained under the mentorship of Professor Reinhold Ganz at the Inselspital in Bern. In 2003, Dr. Parvizi joined the Rothman Orthopaedic Institute and held the position of James Edward Professor of Orthopedic Surgery at Sidney Kimmel School of Medicine until September 2023.
His leadership extends to his roles as president of the MSIS (2013), president of the EOA (2018), and as President of the AAHKS (2023). He is also the co-founder of the ICM a global assembly of experts from 190 countries that convened in Philadelphia in 2013, 2018 and Istanbul in 2025.

Dr. Riew is a Professor of Orthopedic Surgery at Weill-Cornell Medical Center in the Department of Neurological Surgery as well as at Columbia University in the Department of Orthopedic Surgery. His practice is limited to the operative treatment of cervical spine disorders.

Anthony A. Romeo, MD grew up in Pocatello, Idaho in a medically-focused family-his father and all five of his siblings work as healthcare providers. After graduating as Valedictorian of his high school and captain of the football team, Dr. Romeo completed his Bachelor of Science degree at the University of Notre Dame, where he continued his efforts as a varsity football player. He earned his Medical Degree from the St. Louis University School of Medicine before completing his orthopaedic surgery internship and residency at the Cleveland Clinic Foundation. Next, he pursued an Advanced Clinical Experience as a shoulder and elbow surgery fellow at the University of Washington Medical Center in Seattle, guided by Dr. Frederick A Matsen III.

Dr. Romeo has spent his career pursuing excellence in shoulder, elbow, and sports medicine surgery by pioneering new approaches and developing advanced orthopaedic implants and surgical procedures. He currently serves as the Chief Medical Editor of Orthopaedics Today and Director of Romeo Orthopaedics..

With over 450 peer-reviewed publications to his name, Dr. Romeo has contributed to the thought leadership, education, and innovation behind the incredible treatment advances seen over the past three decades. He lives in the Chicago, Illinois metropolitan area with his wife and youngest daughter.

Georg Schett is professor of Internal Medicine and since 2006 Head of the Department of Medicine 3 - Rheumatology and Immunology - of the Friedrich-Alexander-Universität Erlangen-Nürnberg in Germany.
Prof. Schett graduated from the University of Innsbruck (Austria) in 1994. After his dissertation from medical school, he worked as scientist at the Institute of BioMedical Aging Research of the Austrian Academy of Science in Innsbruck. In 1996, he joined the Department of Medicine at the University of Vienna, where he completed his postgraduate training in Internal Medicine and subsequently in Rheumatology. In 2003 he was promoted to professor of Internal Medicine. Before taking up his position as chair of the Department of Medicine 3, he worked as a scientist in the United States for one year.
His scientific work focuses on creating a better understanding of the molecular basis of immune-inflammatory diseases with rapid translation into clinical practice. Initially, he investigated the immunology of atherosclerosis and focused on antibody-mediated endothelial cell damage. His research work led to the understanding of the phenomenon of LE-cells in 2007.
He was awarded the renowned START Award in 2002 and founded a research group for arthritis in Vienna. Prof. Schett is an ERC award winner and speaker of several DFG- and BMBF-funded joint projects. His work has been awarded numerous prizes, including the Carol-Nachman Prize. In March 2023, Prof. Schett received the 2023 Funding Prize in the Gottfried Wilhelm Leibniz Programme awarded by the DFG. He has published over 1100 peer-reviewed articles.

Professor Solimeno is associate professor of Musculoskeletal Diseases and Physical and Rehabilitative Medicine at the University of Milan. He is the Director of the Unit of Orthopedics and Traumatology at the IRCCS Foundation - Ca' Granda - Ospedale Maggiore Policlinico in Milan.
He has been involved in the treatment of hemophilic arthropathy for over forty years.

Linda I. Suleiman, MD is an Associate Professor of Orthopaedic Surgery and Medical Education at Northwestern University Feinberg School of Medicine in Chicago, Illinois. She specializes in hip and knee replacement and reconstruction, with a clinical and academic focus on advancing equitable access to joint arthroplasty.
Dr. Suleiman serves as the Medical Director in the Department of Orthopaedic Surgery and as Associate Dean for Health Equity at Northwestern. She earned her Bachelor of Science in Physiology and Neurobiology from the University of Maryland and her Doctor of Medicine from Howard University College of Medicine. She completed her orthopaedic surgery residency at Northwestern University, followed by a fellowship in adult hip and knee reconstruction at Rush University.
Dr. Suleiman also completed a two-year Health Policy Fellowship with the American Association of Hip and Knee Surgeons (AAHKS). Her research centers on health disparities, access to care, and outcomes in total joint arthroplasty. She currently serves as President of the Ruth Jackson Orthopaedic Society (RJOS), the largest organization for women in orthopaedics and as the Program Chair for the AAHKS Annual Meeting.

Lize van Vulpen is a haematologist at the Van Creveldkliniek, Center for Benign Haematology at the University Medical Center Utrecht in the Netherlands since September 2017. She obtained her medical degree (cum laude) in August 2007 at the University of Utrecht (the Netherlands) and started her training in Internal Medicine and Haematology thereafter. Her clinical training was conducted mainly at the University Medical Center Utrecht, but she also performed a traineeship at the Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK under supervision of prof. M.M. Makris.
She interrupted her residency for a PhD-project on blood-induced joint damage at the department of Rheumatology & Clinical Immunology and the Van Creveldkliniek at the University Medical Center Utrecht under direct supervision of prof. dr. F.P.J.G. Lafeber, dr. R.E.G. Schutgens, and dr. S.C. Mastbergen. This research resulted in her thesis entitled Iron and inflammation: a joint problem in blood-induced arthropathy, and several international awards. She still is involved in translational research unravelling the pathogenesis of haemophilic arthropathy and searching for potential disease modifying interventions.

Tim Wright is the Kirby Chair in Orthopedic Biomechanics at Hospital for Special Surgery and Professor of Applied Biomechanics at Weill Cornell Medical College. He received his doctoral degree from Stanford University, after which he joined Hospital for Special Surgery. His research focuses on orthopedic implant performance through the integration of clinical, radiographic, and biomechanical measures. He has published over three hundred peer-reviewed research articles and helped develop implant systems for knee, hip, and elbow replacement.

Professor Wright has had a long career as an educator mentoring students seeking research training and professional development. He has taught biomechanics to more orthopedic surgeons than anyone through lectures at local hospitals and for national organizations.

His leadership roles include the president of the Orthopedic Research Society and co-editor of the Journal of Orthopedic Research for eighteen years. He has received honors for research excellence from the Hip and Knee Societies and earned a Kappa Delta Award for his outstanding research on polyethylene wear and degradation in total joint components. Professor Wright is a Fellow of the American Institute for Medical and Biological Engineering and a recipient of the Alfred Shands Award from the Orthopedic Research Society for significant lifetime contributions to orthopedics. He is also recipient of the Lifetime Achievement Award from the International Society for Technology in Arthroplasty and the Distinguished Investigator Award from the Orthopedic Research Society and the Orthopedic Research and Education Foundation to honor significant contributions to orthopedic research through outstanding scientific achievements and commitment of time and service.

Dr. Po Ting Wu is Professor and Director of the Department of Orthopedics at National Cheng Kung University Hospital and College of Medicine in Taiwan. He completed his PhD in Biomedical Engineering at National Cheng Kung University, where he also holds joint appointments in the Departments of Biomedical Engineering, and Biochemistry and Molecular Biology. His clinical and scientific interests focus on orthopedic trauma, fracture biology, tendon and cartilage regeneration, and ultrasound guided musculoskeletal interventions. His work integrates regenerative medicine, biomechanics, and translational research to enhance musculoskeletal healing and functional recovery, particularly in fractures and tendinopathy. Dr. Wu has authored more than 80 peer reviewed publications covering tendon biology, fracture treatment, osteoarthritis, peripheral nerve conditions, and innovative orthopedic technologies. He currently serves as a council member of the Taiwan Orthopaedic Research Society, the Taiwan Orthopaedic Trauma Association, the Taiwan Society for Surgery of the Hand, and AO Trauma Taiwan. He has been recognized with multiple national research awards for excellence in orthopedic research. Dr. Wu remains committed to advancing evidence based musculoskeletal care and fostering international collaboration across the Asia Pacific region.

Dr. Jay Wunder - Short Bio

-Undergraduate was in Sciences at the University of Toronto

-Medical School and Orthopaedic Residency were also at the University of Toronto

-Completed a Masters of Science in Molecular Genetics during residency which piqued his interest in sarcomas

- Pursued subspecialty training in Musculoskeletal Oncology with 2 fellowships:
i) with Dr. Robert Bell at Mount Sinai Hospital and Princess Margaret Cancer Center at the University of Toronto
ii) then with Drs. John Healey and Patrick Boland at the Memorial Sloan Kettering Cancer Center in New York

He leads an active peer-review funded sarcoma research program focusing on molecular epidemiology, developmental biology, immune microenvironment, function and quality of life outcomes, and development of novel surgical techniques including tumor prosthesis design and surgical navigation. His group at Mount Sinai runs one of the most sought after and internationally acclaimed orthopaedic oncology fellowship training programs.

Dr. Jay Wunder is a Professor at the University of Toronto, Head of the University of Toronto Musculoskeletal Oncology Unit, and just completed 18 years as Surgeon-in-Chief at Mount Sinai Hospital. He holds the University of Toronto Rubinoff-Gross Chair in Orthopaedic Oncology which supports translational sarcoma research. He is the recipient of numerous teaching awards and peer reviewed sarcoma translational research grants and received the prestigious Kappa Delta Research Award from the Orthopaedic Research Society and the American Academy of Orthopaedic Surgeons on two separate occasions - the highest award for orthopaedic research in North America. He is a past president of the Connective Tissue Oncology Society (CTOS), the foremost organization worldwide promoting advances in patient care and increased knowledge through research for sarcomas and related connective tissue tumors

Dr Simon Young is a specialist knee surgeon based in Auckland New Zealand. He serves as the Director of Orthopaedic Research at North Shore Hospital Associate Professor at the University of Auckland a board member of the New Zealand Joint Registry and the current President of the New Zealand Knee Society.

After completing his orthopaedic training in New Zealand Simon undertook subspecialty fellowship training in the United States in Sports Medicine at Stanford University and in Arthroplasty at the Mayo Clinic.

Simons research on knee replacement is internationally recognized with over 150 peer reviewed publications and multiple prestigious awards including the North American Knee Societys Mark Coventry Award 2013 the Chitranjan Ranawat Award 2016 the John Insall Award 2017 and 2025 and the AAHKS Clinical Research Award 2018 and 2025. His doctoral thesis pioneered the use of intraosseous antibiotic prophylaxis to reduce infection risk in total knee replacement a technique that has influenced surgical protocols worldwide.

His ongoing research focuses on periprosthetic joint infection knee replacement alignment and patient outcomes. He recently led the worlds largest randomized trial on robotic assisted knee replacement surgery conducted in Auckland. Simon is an advocate for evidence based innovation working to translate high quality research into clinical practice.

Mone Zaidi graduated in medicine from King Georges Medical College, India, and trained clinically at the Hammersmith Hospital, London, under Professor Iain MacIntyre, FRS, who discovered calcitonin. After obtaining a PhD and MD from the University of London, Dr. Zaidi held faculty appointments before he was recruited to Mount Sinai School of Medicine as Professor of Medicine and Director of The Mount Sinai Bone Program. He is currently the Mount Sinai Professor of Clinical Medicine and Director of the Institute for Translational Medicine. Zaidi has made groundbreaking discoveries on mechanisms of skeletal homeostasis in health and disease. These studies include the first description of calcium sensing in the osteoclast, the discovery of nitric oxide effects on bone, and the first evidence for a pituitary-bone axis. In recent groundbreaking Nature paper, he found that inhibiting FSH not only increased bone mass but also reduced body fat and prevented neurodegeneration. This work was selected by Nature Medicine as one of eight Notable Advances in biomedicine. Having published over four hundred and ninety papers, Zaidi was elected to the American Society of Clinical Investigation, Association of American Physicians, Interurban Clinical Club, Practitioners Society and Association of Professors of Medicine. He was made Master of the American College of Physicians, elected as Fellow of the American Association of Advancement of Science, National Academy of Inventors, European Academy of Sciences and Academia Europaea, and received the Harrington Innovator Scholar Award, Austrian International Research Prize, Special Recognition Award from the APM, Honorary Fellowship from the British Pharmacological Society, five honorary doctorates, and the Hariett P. Dunstan Prize from the ACP. He was the Commencement Speaker at the University of Connecticut and won the William F. Neuman Award, the highest recognition given by the ASBMR.

Dr. Chunfeng Zhao is Professor of Orthopedic Surgery and Professor of Biomedical Engineering at Mayo Clinic Rochester, where he also serves as Director of the Mayo Biomechanical Core Facility and the Director of Orthopedic Biomechanics Research Laboratory. He has over fifteen years of experience in orthopedic surgery and more than twenty nine years in orthopedic research, with a career spanning leadership role in both clinical and translational science.

Dr. Zhao is a Fellow of the American Institute for Medical and Biological Engineering, presenting the top two present of medical and biological engineering professionals worldwide. Dr. Zhao has made significant contributions to tendon, ligament, and musculoskeletal tissue engineering. He has served as a standing member of the NIH Musculoskeletal Tissue Engineering Study Section and held leadership roles within the Orthopedic Research Society, including Topic Chair for Tendon and Ligament, and member of the Clinical Research, New Investigator Mentoring, and Scientific Program Committees.

His research portfolio includes three hundreds peer reviewed publications and book chapters, as well as multiple U.S. patents. He has been recognized with numerous awards, including the CORR ORS Richard A. Brand Award, the J.R. Neff Award from the Musculoskeletal Transplant Foundation, the Patrick J. Kelly Special Fellows Research Award, and multiple national scientific honors from China. As an active member of the American Academy of Orthopaedic Surgeons, Orthopaedic Research Society, and American Society of Biomechanics, Dr. Zhao is deeply engaged in advancing the field. His research focuses on clinically translational strategies for musculoskeletal disorders, with particular emphasis on soft tissue repair, tendon regeneration, and biomaterial innovation for orthopedic applications.